Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 751 to 775 of 881

Sort by

Type: GuidanceRemove Type: Guidance filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people	TA300	27 November 2013	27 November 2013
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)	TA302	27 November 2013	27 November 2013
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C	TA75	28 January 2004	27 November 2013
Pazopanib for the first-line treatment of advanced renal cell carcinoma	TA215	23 February 2011	1 August 2013
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder	TA292	24 July 2013	24 July 2013
Aflibercept solution for injection for treating wet age‑related macular degeneration	TA294	24 July 2013	24 July 2013
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism	TA287	26 June 2013	26 June 2013
Mirabegron for treating symptoms of overactive bladder	TA290	26 June 2013	26 June 2013
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer	TA284	22 May 2013	22 May 2013
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer	TA285	22 May 2013	22 May 2013
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)	TA286	22 May 2013	22 May 2013
Omalizumab for treating severe persistent allergic asthma	TA278	24 April 2013	24 April 2013
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures	TA279	24 April 2013	24 April 2013
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis	TA276	27 March 2013	27 March 2013
Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal)	TA277	27 March 2013	27 March 2013
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)	TA273	23 January 2013	23 January 2013
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract	TA272	23 January 2013	23 January 2013
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma	TA268	12 December 2012	12 December 2012
Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)	TA270	12 December 2012	12 December 2012
Dronedarone for the treatment of non-permanent atrial fibrillation	TA197	25 August 2010	1 December 2012
Mannitol dry powder for inhalation for treating cystic fibrosis	TA266	28 November 2012	28 November 2012
Ivabradine for treating chronic heart failure	TA267	28 November 2012	28 November 2012
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours	TA265	24 October 2012	24 October 2012
Alteplase for treating acute ischaemic stroke	TA264	26 September 2012	26 September 2012
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer	TA263	22 August 2012	22 August 2012

Results per page

10
25
50
All